Helicobacter pylori in children and adolescents

Gisela Chelimsky1, Samra S Blanchard, Steven J Czinn

  • 1Department of Pediatrics, Division of Gastroenterology, Rainbow Babies & Children's Hospital, Case Western Reserve University, Hospital 11100 Euclid Avenue, Cleveland, OH 44106, USA. gisela.chelimsky@uhhs.com

Insights

Helicobacter pylori (H. pylori) is a human pathogen strongly linked to gastroduodenal diseases. Current treatment for H. pylori-associated peptic ulcers involves proton pump inhibitors and antibiotics.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pathogenesis

Background:

  • Helicobacter pylori is recognized as a significant human pathogen.
  • A strong association exists between H. pylori infection and gastroduodenal diseases.
  • Pathogenic mechanisms are hypothesized to involve bacterial factors, inflammation, acid secretion dysregulation, and host immune responses.

Purpose of the Study:

  • To review the evidence supporting H. pylori as a human pathogen.
  • To discuss proposed mechanisms of H. pylori-induced gastroduodenal disease.
  • To outline current treatment recommendations for H. pylori-associated peptic ulcer disease.

Main Methods:

  • Review of existing scientific literature and evidence.
  • Analysis of proposed pathogenic mechanisms.
  • Summary of established treatment protocols.

Main Results:

  • Considerable evidence confirms H. pylori as a human pathogen.
  • The link between H. pylori and gastroduodenal disease is well-documented.
  • Multiple hypotheses explain H. pylori's role in disease development.

Conclusions:

  • H. pylori is a confirmed human pathogen with a significant role in gastroduodenal pathology.
  • Understanding pathogenic mechanisms is crucial for disease management.
  • Combination therapy with proton pump inhibitors and antimicrobials remains the standard treatment for H. pylori-related peptic ulcers.

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...